Today we're joined by Ivan Kairatov, a Biopharma expert at the forefront of integrating technology and innovation into medical training. We’ll be exploring a groundbreaking initiative that uses ambient AI to transform medical education, moving from sporadic feedback to a model where every clinical
A groundbreaking collaboration is set to address a critical paradox in modern medicine, where potentially life-saving therapies for ultra-rare diseases are abandoned not for lack of scientific merit, but due to insufficient commercial appeal. The American Society of Gene & Cell Therapy (ASGCT) and
Today we sit down with Dr. Ivan Kairatov, a veteran biopharma expert whose work at the intersection of medicinal chemistry and computational biology is pushing the boundaries of treatment for central nervous system disorders. For decades, the neurokinin-1 receptor, or NK1R, was a tantalizing but
In the digital age of medicine, clinicians are paradoxically drowning in an ocean of patient data while simultaneously thirsting for clear, actionable insights at the point of care. The emergence of AI-Powered Chart Review represents a significant advancement in the healthcare technology sector,
The daunting reality for thousands of individuals is that a diagnosis of end-stage liver failure begins a desperate race against time, a wait for a life-saving organ that, for many, will never arrive. This critical shortage of donor organs has created a persistent crisis in modern medicine, with
We are joined today by Ivan Kairatov, a biopharma expert with deep insights into the technological innovations shaping the future of medicine. We will be exploring the recent expansion of a groundbreaking protein discovery platform into Asia, discussing its installation at two leading Taiwanese
